Joseph Knowles
Co-Founder & Member of Scientific Advisory BoardDr. Jak Knowles, M.D., also known as Jak, is a Co-Founder of Metagenomi Therapeutics, Inc. (formerly known as Metagenomi, Inc.) since October 2020 and serves as its Member of Scientific Advisory Board and was its Chief Business Officer since October 2020. He served as President at Exonics Therapeutics, Inc. He has been Vice President of Medical and Scientific Affairs at CureDuchenne since September 15, 2015. He is a Managing Director of CureDuchenne Ventures. Dr. Knowles served as an Associate at MPM Capital. He joined the MPM Capital in 2014. Prior to MPM, he has worked as a Biotechnology Equities Analyst with JMP Securities and with Burrill & Company. In 2010, he was in the Health and Life Sciences consulting practice at Oliver Wyman and helped implement value-based care within US payor and provider systems. Prior to joining Bayer, Jak served as CEO of CytoSen Therapeutics, where he worked to develop Natural Killer cell immunotherapies for oncology indications. Dr. Knowles has authored over a dozen research publications from work performed at the Memorial Sloan Kettering Cancer Center, Stanford University. He served on the Board of Directors for Century Therapeutics, Pyxis Oncology, Metagenomi Technologies, Vesigen Therapeutics and NewLeaf Symbiotics. He served as a Director of Triumvira Immunologics USA, Inc. until October 2020. He served as Interim Chief Executive Officer at Exonics Therapeutics, Inc. Dr. Knowles completed a Post-Doctoral Research Fellowship in Head and Neck Cancer and performed surgical training within the department of Otolaryngology at the University of Alabama at Birmingham and received his M.D. in Bioengineering and Biomedical Engineering from Stanford University (2003-2007) and a B.S. in Biological Sciences/Biology from Binghamton University(1997-2001).
Positions
- Company NameMetagenomi Therapeutics, Inc.Stock CodeMGXPositionCo-Founder & Member of Scientific Advisory BoardColleagues
- JIJian IrishCEO, President & Director
- WHWillard H. DereIndependent Board Chair
- PMPamela M. WapnickChief Financial Officer
- MLMatthew L. WeinGeneral Counsel, Compliance Officer, Head of BD&L and Corporate Secretary
- MLMark LeonardSenior Vice President of Technical Development & Operations
- EHEric H. BjerkholtIndependent Director
- LELaurence E. ReidIndependent Director
